Fundies.
English

Segment disclosures

Company overview

Cidara Therapeutics, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 12 retained observations 8 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cdtx:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-07-01 – 2025-09-300 USD20251106Open filing evidence
2025-01-01 – 2025-09-300 USD20251106Open filing evidence
2025-04-01 – 2025-06-300 USD20250807Open filing evidence
2025-01-01 – 2025-06-300 USD20250807Open filing evidence
2025-01-01 – 2025-03-310 USD20250508Open filing evidence
2024-01-01 – 2024-12-311275000 USD20250306Open filing evidence
2024-07-01 – 2024-09-300 USD20251106Open filing evidence
2024-01-01 – 2024-09-301275000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30302000 USD20250807Open filing evidence
2024-01-01 – 2024-06-301275000 USD20250807Open filing evidence
2024-01-01 – 2024-03-31973000 USD20250508Open filing evidence
2023-01-01 – 2023-12-3123283000 USD20250306Open filing evidence